Goldman Sachs lowers Corteva stock price target to $20 post-spinoff
Covered in this story
What has happened since
- Corteva is down 6.6% since this was published, 12 days ago.
- Goldman Sachs is up 0.4% since this was published, 12 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
RBC Capital Markets’s $17 target on $CTVA is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
RBC Capital Markets’s track record →Tracked from this story
Oppenheimer’s $17 target on $CTVA is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Oppenheimer’s track record →Tracked from this story
Goldman Sachs’s $20 target on $CTVA is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Goldman Sachs’s track record →Analyst targets on Corteva
- KeyBanc Capital Markets: $13.9 → $17 by Oct 2027 · Overweight via Investing.com
- JPMorgan: $12.4 → $19 by Oct 2027 · Overweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CTVA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Corteva →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.